Nathaniel Herzfeld

Array ( [id] => 10155680 [patent_doc_number] => 09187438 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-17 [patent_title] => 'Derivatives of benzothiazines, preparation thereof and application thereof as drugs' [patent_app_type] => utility [patent_app_number] => 13/254473 [patent_app_country] => US [patent_app_date] => 2010-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34035 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13254473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7791563 [patent_doc_number] => 20120053119 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-01 [patent_title] => 'THERAPEUTIC METHOD FOR INCREASING PANCREATIC BETA CELL MASS' [patent_app_type] => utility [patent_app_number] => 13/201100 [patent_app_country] => US [patent_app_date] => 2010-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 16484 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20120053119.pdf [firstpage_image] =>[orig_patent_app_number] => 13201100 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8128337 [patent_doc_number] => 20120088715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-12 [patent_title] => 'MUTATED ANTITHROMBINS, A PROCESS FOR PREPARING THE SAME AND THEIR USE AS DRUGS' [patent_app_type] => utility [patent_app_number] => 13/144995 [patent_app_country] => US [patent_app_date] => 2010-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17339 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20120088715.pdf [firstpage_image] =>[orig_patent_app_number] => 13144995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6237418 [patent_doc_number] => 20100267928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'ACTIVATABLE DIAGNOSTIC AND THERAPEUTIC COMPOUND' [patent_app_type] => utility [patent_app_number] => 12/634972 [patent_app_country] => US [patent_app_date] => 2009-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10273 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20100267928.pdf [firstpage_image] =>[orig_patent_app_number] => 12634972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9777679 [patent_doc_number] => 08852883 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-07 [patent_title] => 'Rapid FRET-based diagnosis of bacterial pathogens' [patent_app_type] => utility [patent_app_number] => 13/130213 [patent_app_country] => US [patent_app_date] => 2009-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 11 [patent_no_of_words] => 5582 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13130213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7560915 [patent_doc_number] => 20110274747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'C-Terminal Fragments of Glucagon-Like Peptide-1 (GLP-1)' [patent_app_type] => utility [patent_app_number] => 13/127387 [patent_app_country] => US [patent_app_date] => 2009-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8193 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20110274747.pdf [firstpage_image] =>[orig_patent_app_number] => 13127387 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9286207 [patent_doc_number] => 08642536 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-04 [patent_title] => 'Method of making biologically active alpha-beta peptides' [patent_app_type] => utility [patent_app_number] => 12/578993 [patent_app_country] => US [patent_app_date] => 2009-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 33 [patent_no_of_words] => 18700 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12578993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7490992 [patent_doc_number] => 20110237774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'METHOD FOR INTRODUCING DOTA' [patent_app_type] => utility [patent_app_number] => 13/123137 [patent_app_country] => US [patent_app_date] => 2009-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6006 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0237/20110237774.pdf [firstpage_image] =>[orig_patent_app_number] => 13123137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11773469 [patent_doc_number] => 09382306 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-07-05 [patent_title] => 'Octapeptide compounds derived from somatostatin and the therapeutic use thereof' [patent_app_type] => utility [patent_app_number] => 13/121928 [patent_app_country] => US [patent_app_date] => 2009-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23107 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13121928 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7511376 [patent_doc_number] => 20110257086 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'METHODS FOR SYNTHESIS AND USES OF INHIBITORS OF GHRELIN O-ACYLTRANSFERASE AS POTENTIAL THERAPEUTIC AGENTS FOR OBESITY AND DIABETES' [patent_app_type] => utility [patent_app_number] => 13/122438 [patent_app_country] => US [patent_app_date] => 2009-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12216 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257086.pdf [firstpage_image] =>[orig_patent_app_number] => 13122438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7587278 [patent_doc_number] => 20110281788 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'ANTI FUNGAL THERAPY' [patent_app_type] => utility [patent_app_number] => 13/119806 [patent_app_country] => US [patent_app_date] => 2009-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5482 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20110281788.pdf [firstpage_image] =>[orig_patent_app_number] => 13119806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6202862 [patent_doc_number] => 20110065648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-17 [patent_title] => 'ADVANTAGEOUS MU-OPIATE RECEPTOR PEPTIDE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/559994 [patent_app_country] => US [patent_app_date] => 2009-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2064 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20110065648.pdf [firstpage_image] =>[orig_patent_app_number] => 12559994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6046892 [patent_doc_number] => 20110206752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'COMPOSITIONS FOR THE TREATMENT OF PAIN AND/OR INFLAMATION' [patent_app_type] => utility [patent_app_number] => 13/055598 [patent_app_country] => US [patent_app_date] => 2009-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12839 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20110206752.pdf [firstpage_image] =>[orig_patent_app_number] => 13055598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7511368 [patent_doc_number] => 20110257078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'ANTIBACTERIAL COMBINATION THERAPY FOR THE TREATMENT OF GRAM POSITIVE BACTERIAL INFECTIONS' [patent_app_type] => utility [patent_app_number] => 13/054491 [patent_app_country] => US [patent_app_date] => 2009-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9729 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257078.pdf [firstpage_image] =>[orig_patent_app_number] => 13054491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6000936 [patent_doc_number] => 20110117206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'PHOSPHOPEPTIDES AND USE OF THE SAME' [patent_app_type] => utility [patent_app_number] => 13/054027 [patent_app_country] => US [patent_app_date] => 2009-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 31009 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20110117206.pdf [firstpage_image] =>[orig_patent_app_number] => 13054027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9355318 [patent_doc_number] => 08673850 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-18 [patent_title] => 'PCSK9 inhibitors and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/994835 [patent_app_country] => US [patent_app_date] => 2009-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 52 [patent_no_of_words] => 26606 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12994835 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9441071 [patent_doc_number] => 08710183 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-29 [patent_title] => 'Inhibitors of bacterial tyrosine kinase and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/990090 [patent_app_country] => US [patent_app_date] => 2009-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11295 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12990090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10050838 [patent_doc_number] => 09090705 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-28 [patent_title] => 'Process for preparation of insulin compounds' [patent_app_type] => utility [patent_app_number] => 13/057317 [patent_app_country] => US [patent_app_date] => 2008-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8549 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13057317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10187616 [patent_doc_number] => 09217027 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-22 [patent_title] => 'Thrombin inhibitor' [patent_app_type] => utility [patent_app_number] => 12/665256 [patent_app_country] => US [patent_app_date] => 2008-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 32 [patent_no_of_words] => 21852 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12665256 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6320280 [patent_doc_number] => 20100113327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'METHODS FOR CONTROLLING MINERALIZATION OF EXTRACELLULAR MATRIX, THERAPEUTIC METHODS BASED THEREON AND MEDICAMENTS FOR USE THEREIN' [patent_app_type] => utility [patent_app_number] => 12/515202 [patent_app_country] => US [patent_app_date] => 2007-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 20323 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113327.pdf [firstpage_image] =>[orig_patent_app_number] => 12515202 [rel_patent_id] =>[rel_patent_doc_number] =>)